New Zealand markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
171.36-11.49 (-6.28%)
At close: 04:00PM EST
171.36 0.00 (0.00%)
After hours: 06:03PM EST
Full screen
Trade prices are not sourced from all markets
Previous close182.85
Bid170.00 x 800
Ask188.88 x 800
Day's range170.25 - 185.54
52-week range121.98 - 212.00
Avg. volume604,493
Market cap20.495B
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)-7.13
Earnings date09 Feb 2022 - 14 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est207.10
  • Business Wire

    Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021

    CAMBRIDGE, Mass., December 02, 2021--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it has ranked first in Boston Globe’s 2021 Top Places to Work in the "Largest Employer" category. This is the seventh consecutive year that Alnylam has been named a Top Place to Work by the Boston Globe and the first year that Alnylam has been eligible for the Largest Employer category (> 1,000 employees).

  • Business Wire

    Alnylam to Webcast Presentations at Upcoming Investor Conferences

    CAMBRIDGE, Mass., November 23, 2021--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences being held virtually:

  • Motley Fool

    4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

    The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.